Photo of Kelly S. Perlewitz, MD

Kelly S. Perlewitz, MD

Accepting New Patients
1000 North Providence Drive, Suite 310
Newberg, OR 97132
2043.1 miles away
Medical Groups & Affiliations
Providence Medical Group - Oregon
Speaks: English
map

Providence Cancer Institute - Newberg

1000 North Providence Drive, Suite 310, Newberg, OR 97132

Are you covered?

Check to see if your insurance is covered by this provider.

About Kelly S. Perlewitz

"I view myself as partner and advisor to my patients and their family members. I understand that a cancer diagnosis and treatment can be overwhelming and I believe that it is my role to provide education and guidance, so that every patient and their family may have an integral part in the decision making process." - Kelly Perlewitz, M.D.

Fellowship

Oregon Health & Science University School of Medicine
2010

Medical School

Rutgers Robert Wood Johnson Medical School
2004

Residency

Temple University School of Medicine
2007

Board Certifications
  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Medical Oncology
Providence Cancer Institute - Newberg
1000 North Providence Drive, Suite 310
Newberg, OR 97132

Medical Groups & Affiliations
Providence Medical Group - Oregon

Affiliated Locations
Providence St. Vincent Medical Center
Providence Seaside Hospital
Providence Willamette Falls Medical Center
Providence Newberg Medical Center
Providence Hood River Memorial Hospital
Providence Portland Medical Center

Clinical Interests

  • Adrenal Neoplasm
  • Anal Cancer
  • Anaplastic Meningioma
  • Anemia
  • Anorectal Cancer
  • Antithrombin Deficiency
  • Atypical Ductal Hyperplasia
  • Bladder Cancer
  • Breast Cancer
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoid Tumor
  • Carcinoma In Situ Of Breast
  • Carcinoma Of Unknown Primary
  • Cervical Cancer
  • Chemoradiation
  • Chest Wall Tumors
  • Cholangiocarcinoma
  • Clinical Trials
  • Colon Cancer
  • Colorectal Cancer
  • Colorectal Metastases
  • Crizotinib
  • Ductal Carcinoma In Situ (Dcis)
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Erlotinib
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastroesophageal Junction Cancer
  • Head And Neck Cancer
  • Hereditary Breast And Ovarian Cancer
  • Hypopharyngeal Cancer
  • Islet Cell Tumor
  • Kidney Cancer
  • Laryngeal Cancer
  • Leukemia
  • Lobular Carcinoma In Situ (Lcis)
  • Lung Cancer
  • Lung Metastasis
  • Lymphedema Therapy
  • Lymphoma
  • Lynch Syndrome
  • Male Breast Cancer
  • Malignant Neoplasm Of Esophagus
  • Malignant Neoplasm Of Liver
  • Mediastinal Mass
  • Melanoma
  • Mesothelioma
  • Metastatic Liver Cancer
  • Metastatic Melanoma
  • Metastatic Squamous Neck Cancer With Occult Primary
  • Metastatic Tumors To The Lungs
  • Mouth Cancer
  • Mucosal Melanoma
  • Multiple Myeloma
  • Nasopharyngeal Cancer
  • Neoplasm Of Salivary Gland
  • Neuroendocrine Tumors
  • Non Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Ovarian Cancer
  • Pancreas Cancer
  • Paranasal Sinus And Nasal Cavity Cancer
  • Prostate Cancer
  • Pulmonary Metastases
  • Retroperitoneal Mass
  • Side Effects Of Cancer Treatment
  • Skeletal Metastasis
  • Skin Cancer
  • Small Bowel Cancer
  • Small Cell Lung Cancer
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer
  • Targeted Molecular Therapy
  • Testicular Cancer
  • Thoracic Cancer
  • Thoracic Malignancy
  • Thymoma
  • Thyroid Cancer
  • Tongue Cancer
  • Tracheal Cancer
  • Tracheal Mass
  • Unknown Primary Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vaginal Melanoma
  • Vulvar Cancer